This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Biocis Pharma Oy. Active years: 2012-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2014
Title: Jarmo Laihia: Innovator in Pharmaceutical Composition
Introduction
Jarmo Laihia is a notable inventor based in Lieto, Finland. He has made significant contributions to the field of pharmaceuticals, particularly in the area of intracellular acidification. With a total of 4 patents to his name, Laihia's work has the potential to impact immunosuppression therapies.
Latest Patents
Laihia's latest patents include a pharmaceutical composition for intracellular acidification with cis-urocanic acid. This composition is designed to acidify the cell cytoplasm, making it useful for causing immunosuppression in both humans and animals. The agent is administered in an essentially non-dissociated form, and it is mixed with a carrier to adjust the pH of the composition to a range of 6.1 to 7.0. This innovative approach highlights Laihia's commitment to advancing pharmaceutical science.
Career Highlights
Throughout his career, Jarmo Laihia has worked with several companies, including Biocis Pharma Oy and Finnsusp Ab. His experience in these organizations has allowed him to develop and refine his inventions, contributing to the advancement of pharmaceutical technologies.
Collaborations
Laihia has collaborated with various professionals in his field, including his coworker Lasse Leino. These partnerships have facilitated the exchange of ideas and fostered innovation in pharmaceutical research.
Conclusion
Jarmo Laihia's contributions to pharmaceutical compositions demonstrate his dedication to improving medical treatments. His innovative patents and collaborations reflect his significant role in the field of pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile